Intuitive Surgical (ISRG) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
The meeting was hosted both virtually and in person to increase inclusivity and introduced the board, management, and key external partners.
The agenda included formal business, consideration of six proposals, a business overview, and a Q&A session.
Board and executive committee updates
Eleven directors were nominated and elected to serve until the 2026 annual meeting.
Mark Rubash, a long-serving board member and former audit committee chair, was recognized for his contributions as this was his last meeting.
Shareholder proposals
Two shareholder proposals were presented: one to improve the executive compensation program by including a CEO pay ratio factor, and another to require shareholder approval for excessive golden parachutes.
Both proposals were discussed by their proponents and recommended against by the board.
Latest events from Intuitive Surgical
- Board recommends approval of all annual meeting proposals, including director elections and compensation.ISRG
Proxy Filing13 Mar 2026 - Shareholders to vote on board, pay, auditor, and equity plan amid strong growth and governance.ISRG
Proxy Filing13 Mar 2026 - Q2 revenue up 14% to $2.01B–$2.2B, driven by strong procedure and system growth.ISRG
Q2 20243 Feb 2026 - Strong 2025 growth and da Vinci 5 adoption drive continued expansion into 2026.ISRG
Q4 202522 Jan 2026 - Da Vinci 5 launch drives strong placements and positive feedback, supporting robust financial outlook.ISRG
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Q3 2024 revenue up 17% to $2.04B, net income up 36% to $565M, with strong system growth.ISRG
Q3 202419 Jan 2026 - Record growth, innovation, and digital expansion set the stage for global priorities in 2026.ISRG
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Da Vinci 5 launch, innovation, and global growth drive momentum in minimally invasive care.ISRG
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q4 2024 revenue up 25% with strong da Vinci growth; 2025 outlook cautious on margins.ISRG
Q4 20249 Jan 2026